|
Q4 FY2024
As of Sep 30, 2024
|
Q4 FY2023
As of Sep 30, 2023
|
|
|---|---|---|
| Current assets | ||
| Cash | ||
| Trade receivable and other receivables | ||
| Government assistance and R&D tax credits receivable | ||
| Government assistance and R&D tax credit receivable | ||
| Inventories | ||
| Prepaid expenses | ||
| Total current assets | ||
| Property and equipment | ||
| Right-of-use assets | ||
| Intangible assets | ||
| Prepaid financing fees | ||
| Goodwill | ||
| Total non-current assets | ||
| Total assets | ||
| Current liabilities | ||
| Accounts payable and accrued liabilities | ||
| Provisions | ||
| Conversion option | ||
| Warrant liability | ||
| Bridge loans | ||
| Current portion of lease liabilities | ||
| Current portion of long-term debt | ||
| Current portion of government grant liabilities | ||
| Total current liabilities | ||
| Long-term debt | ||
| Redeemable stock options | ||
| Lease liabilities | ||
| Government grant liabilities | ||
| Total non-current liabilities | ||
| Total liabilities | ||
| Shareholders’ deficiency | ||
| Capital stock | ||
| Reserve – warrants | ||
| Reserve – stock options | ||
| Other component of equity | ||
| Deficit | ||
| Equity (deficiency) attributable to owners of the capital stock of the parent | ||
| Non-controlling interests | ||
| Total shareholders’ deficiency | ||
| Total liabilities and shareholders’ deficiency |
Loading...
